{Reference Type}: Journal Article
{Title}: Amphetamine use for attention deficit hyperactive disorder during breastfeeding and children's neurodevelopmental outcomes: A pilot study.
{Author}: Benassayag Kaduri N;Hazan A;De-Haan T;Kohn E;Berkovitch M;Berlin M;
{Journal}: Psychiatry Res
{Volume}: 339
{Issue}: 0
{Year}: 2024 Jun 17
{Factor}: 11.225
{DOI}: 10.1016/j.psychres.2024.116047
{Abstract}: Attention deficit hyperactive disorder (ADHD) medication use rises among women of childbearing age and during pregnancy. Little is known on the safety of amphetamine stimulants for ADHD treatment during breastfeeding. Most data on the safety of these medications are from recreational abuse of methamphetamine. This study followed children (N = 13) exposed to amphetamine stimulants during breastfeeding. Assessments by Pediatric Quality of Life and Denver Developmental Scale evaluated neurodevelopment and outcomes. Study results showed normal neurodevelopment with no significant adverse effects. Findings suggest amphetamines are likely compatible with breastfeeding; however larger studies are needed.